16 min read
Keypoint Newsletter: Welcome to the Fellows Class of 2023
By Heather Gerhart
Keystone Symposia is pleased to introduce the Keystone Symposia Fellows Class of 2023! This year we...
Dr. Livia Yamashiro is a Scientist at Arcus Biosciences where she applies fundamental immunology to the development of drugs for cancer immunotherapies. Her focus is to phenotype immune responses and validate the application of promising candidates in clinical trials. She also investigates compounds with cancer cell-intrinsic activity, aiming to find molecules with selective activity towards tumoral cells avoiding unspecific effects. Livia has a background in immunology related to host innate immune system-pathogen interactions having studied the Stimulator of Interferon Genes (STING) pathway and the downstream effects on infectious diseases during her postdoctoral fellowship at UC Berkeley. Additionally, Livia has been involved in the screening of compounds with antiviral activity against SARS-CoV-2 and successfully established animal models to investigate top hit candidates.
Research Area(s):
ImmunologyResearch Keywords:
Mentor: Deepak Sampath, PhD
Dec 8, 2022 by Keystone Symposia
By Heather Gerhart
Keystone Symposia is pleased to introduce the Keystone Symposia Fellows Class of 2023! This year we...
Mar 29, 2022 by Shannon Weiman
Keystone Symposia was founded on the idea of bringing academic and industry scientists together to accelerate...